Limmi

About Limmi

Limmi is a data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery.

```xml <problem> Analyzing complex, multi-modal clinical datasets to identify patterns and accelerate drug and biomarker discovery is often hindered by the time-consuming process of importing and cleaning data. Researchers often face delays in obtaining actionable insights due to the manual effort required to prepare data for analysis. </problem> <solution> Limmi is an AI-powered data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models and algorithms. The platform automatically collects and structures data from various sources, including EHR records, clinical studies, and genomic databases, eliminating the need for manual data preparation. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery. The platform also includes features for automated real-world analysis and trending, allowing users to unlock new insights in their data. </solution> <features> - Automated data import and cleaning from EHR records, clinical studies, and genomic databases - Support for multi-modal data analysis, combining genetic, longitudinal, and other data types - Access to over 60 statistical models and algorithms - Automated real-world analysis and trending - Traceability feature that logs all data and user actions for FDA and HIPPA compliance - Model monitoring from training to development, tracking model drift and other parameters </features> <target_audience> Limmi is designed for researchers, scientists, and data analysts in the pharmaceutical, biotechnology, and healthcare industries who need to analyze complex clinical data to accelerate drug and biomarker discovery. </target_audience> ```

What does Limmi do?

Limmi is a data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery.

Where is Limmi located?

Limmi is based in Carlsbad, United States.

When was Limmi founded?

Limmi was founded in 2022.

How much funding has Limmi raised?

Limmi has raised 860000.

Location
Carlsbad, United States
Founded
2022
Funding
860000
Employees
4 employees
Major Investors
Vinergy Capital
Looking for specific startups?
Try our free semantic startup search

Limmi

Score: 87/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

Limmi is a data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery.

limmi.io300+
cb
Crunchbase
Founded 2022 – Carlsbad, United States

Funding

$

Estimated Funding

$860K+

Major Investors

Vinergy Capital

Team (<5)

Rob Lozuk

Chief Executive Officer

Bryan Ivory

President/CTO

Company Description

Problem

Analyzing complex, multi-modal clinical datasets to identify patterns and accelerate drug and biomarker discovery is often hindered by the time-consuming process of importing and cleaning data. Researchers often face delays in obtaining actionable insights due to the manual effort required to prepare data for analysis.

Solution

Limmi is an AI-powered data analysis platform that automates the import and cleaning of clinical data, enabling researchers to analyze multi-modal datasets using over 60 statistical models and algorithms. The platform automatically collects and structures data from various sources, including EHR records, clinical studies, and genomic databases, eliminating the need for manual data preparation. By streamlining data preparation, Limmi reduces the time from data collection to actionable insights, facilitating faster drug and biomarker discovery. The platform also includes features for automated real-world analysis and trending, allowing users to unlock new insights in their data.

Features

Automated data import and cleaning from EHR records, clinical studies, and genomic databases

Support for multi-modal data analysis, combining genetic, longitudinal, and other data types

Access to over 60 statistical models and algorithms

Automated real-world analysis and trending

Traceability feature that logs all data and user actions for FDA and HIPPA compliance

Model monitoring from training to development, tracking model drift and other parameters

Target Audience

Limmi is designed for researchers, scientists, and data analysts in the pharmaceutical, biotechnology, and healthcare industries who need to analyze complex clinical data to accelerate drug and biomarker discovery.